Pulmonx (LUNG) Revenue Growth (3y) (2022 - 2025)
Pulmonx (LUNG) Revenue Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.83 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.98 Bn | 99.76 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.01 Bn | 44.34 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 0.73% |
| 10 | Pulmonx | 49.12 Mn | -20.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16.78% |
| Jun 30, 2025 | 19.59% |
| Mar 31, 2025 | 27.85% |
| Dec 31, 2024 | 20.13% |
| Sep 30, 2024 | 15.41% |
| Jun 30, 2024 | 19.42% |
| Mar 31, 2024 | 26.82% |
| Dec 31, 2023 | 25.17% |
| Sep 30, 2023 | 18.52% |
| Jun 30, 2023 | 67.28% |
| Mar 31, 2023 | 19.03% |
| Dec 31, 2022 | 14.24% |
| Sep 30, 2022 | 14.04% |